BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 7480705)

  • 1. H-1 MR spectroscopic imaging of white matter signal hyperintensities: Alzheimer disease and ischemic vascular dementia.
    Constans JM; Meyerhoff DJ; Gerson J; MacKay S; Norman D; Fein G; Weiner MW
    Radiology; 1995 Nov; 197(2):517-23. PubMed ID: 7480705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional gray and white matter metabolite differences in subjects with AD, with subcortical ischemic vascular dementia, and elderly controls with 1H magnetic resonance spectroscopic imaging.
    MacKay S; Meyerhoff DJ; Constans JM; Norman D; Fein G; Weiner MW
    Arch Neurol; 1996 Feb; 53(2):167-74. PubMed ID: 8639067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.
    Bladowska J; Zimny A; Knysz B; Małyszczak K; Kołtowska A; Szewczyk P; Gąsiorowski J; Furdal M; Sąsiadek MJ
    J Hepatol; 2013 Oct; 59(4):651-7. PubMed ID: 23680314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcortical ischemic vascular dementia: assessment with quantitative MR imaging and 1H MR spectroscopy.
    Capizzano AA; Schuff N; Amend DL; Tanabe JL; Norman D; Maudsley AA; Jagust W; Chui HC; Fein G; Segal MR; Weiner MW
    AJNR Am J Neuroradiol; 2000 Apr; 21(4):621-30. PubMed ID: 10782769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in DWI and MRS associated with white matter hyperintensities in elderly subjects.
    Firbank MJ; Minett T; O'Brien JT
    Neurology; 2003 Oct; 61(7):950-4. PubMed ID: 14557566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1H MR spectroscopy in common dementias.
    Kantarci K; Petersen RC; Boeve BF; Knopman DS; Tang-Wai DF; O'Brien PC; Weigand SD; Edland SD; Smith GE; Ivnik RJ; Ferman TJ; Tangalos EG; Jack CR
    Neurology; 2004 Oct; 63(8):1393-8. PubMed ID: 15505154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer disease and subcortical ischemic vascular dementia: evaluation by combining MR imaging segmentation and H-1 MR spectroscopic imaging.
    MacKay S; Ezekiel F; Di Sclafani V; Meyerhoff DJ; Gerson J; Norman D; Fein G; Weiner MW
    Radiology; 1996 Feb; 198(2):537-45. PubMed ID: 8596863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Region and tissue differences of metabolites in normally aged brain using multislice 1H magnetic resonance spectroscopic imaging.
    Schuff N; Ezekiel F; Gamst AC; Amend DL; Capizzano AA; Maudsley AA; Weiner MW
    Magn Reson Med; 2001 May; 45(5):899-907. PubMed ID: 11323817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive impairment: assessment with brain magnetic resonance imaging and proton magnetic resonance spectroscopy.
    Weiss U; Bacher R; Vonbank H; Kemmler G; Lingg A; Marksteiner J
    J Clin Psychiatry; 2003 Mar; 64(3):235-42. PubMed ID: 12716263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton magnetic resonance spectroscopy of vascular- and Alzheimer-type dementia.
    Kattapong VJ; Brooks WM; Wesley MH; Kodituwakku PW; Rosenberg GA
    Arch Neurol; 1996 Jul; 53(7):678-80. PubMed ID: 8929176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (1)H MR spectroscopy of the brain in multiple sclerosis subtypes with analysis of the metabolite concentrations in gray and white matter: initial findings.
    Sijens PE; Mostert JP; Oudkerk M; De Keyser J
    Eur Radiol; 2006 Feb; 16(2):489-95. PubMed ID: 16028056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relapsing-remitting multiple sclerosis: metabolic abnormality in nonenhancing lesions and normal-appearing white matter at MR imaging: initial experience.
    He J; Inglese M; Li BS; Babb JS; Grossman RI; Gonen O
    Radiology; 2005 Jan; 234(1):211-7. PubMed ID: 15528260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging.
    Meyerhoff DJ; MacKay S; Constans JM; Norman D; Van Dyke C; Fein G; Weiner MW
    Ann Neurol; 1994 Jul; 36(1):40-7. PubMed ID: 8024260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor analysis of proton MR spectroscopic imaging data in HIV infection: metabolite-derived factors help identify infection and dementia.
    Mohamed MA; Lentz MR; Lee V; Halpern EF; Sacktor N; Selnes O; Barker PB; Pomper MG
    Radiology; 2010 Feb; 254(2):577-86. PubMed ID: 20093528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MR imaging and proton MR spectroscopic studies in Sjögren-Larsson syndrome: characterization of the leukoencephalopathy.
    Willemsen MA; Van Der Graaf M; Van Der Knaap MS; Heerschap A; Van Domburg PH; Gabreëls FJ; Rotteveel JJ
    AJNR Am J Neuroradiol; 2004 Apr; 25(4):649-57. PubMed ID: 15090362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1H-MR spectroscopy metabolite levels correlate with executive function in vascular cognitive impairment.
    Gasparovic C; Prestopnik J; Thompson J; Taheri S; Huisa B; Schrader R; Adair JC; Rosenberg GA
    J Neurol Neurosurg Psychiatry; 2013 Jul; 84(7):715-21. PubMed ID: 23418212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1H and 31P magnetic resonance spectroscopic imaging of white matter signal hyperintensity areas in elderly subjects.
    Constans JM; Meyerhoff DJ; Norman D; Fein G; Weiner MW
    Neuroradiology; 1995 Nov; 37(8):615-23. PubMed ID: 8748891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic changes in normal-appearing white matter in patients with neuromyelitis optica and multiple sclerosis: a comparative magnetic resonance spectroscopy study.
    Duan Y; Liu Z; Liu Y; Huang J; Ren Z; Sun Z; Chen H; Dong H; Ye J; Li K
    Acta Radiol; 2017 Sep; 58(9):1132-1137. PubMed ID: 28173728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton magnetic resonance spectroscopy of human brain: applications to normal white matter, chronic infarction, and MRI white matter signal hyperintensities.
    Sappey-Marinier D; Calabrese G; Hetherington HP; Fisher SN; Deicken R; Van Dyke C; Fein G; Weiner MW
    Magn Reson Med; 1992 Aug; 26(2):313-27. PubMed ID: 1513253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different patterns of N-acetylaspartate loss in subcortical ischemic vascular dementia and AD.
    Schuff N; Capizzano AA; Du AT; Amend DL; O'Neill J; Norman D; Jagust WJ; Chui HC; Kramer JH; Reed BR; Miller BL; Yaffe K; Weiner MW
    Neurology; 2003 Aug; 61(3):358-64. PubMed ID: 12913198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.